MyFinsight
Home
Compare
About
Recent SEC Filings
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Balance Sheets Overview
Current Ratio
694.70%
Quick Ratio
694.70%
Cash Ratio
416.83%
Debt to Asset Ratio
17.45%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Short-term investments
Goodwill
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
2022 usd financing warrants
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
Cash and cash equivalents
655,267
262,518
257,837
Short-term investments
428,612
110,904
153,756
Prepaid and other current assets
8,222
7,141
7,727
Total current assets
1,092,101
380,563
419,320
Goodwill
19,918
19,918
19,918
Other non-current assets
880
812
862
Total assets
1,112,899
401,293
440,100
Accounts payable
6,965
7,127
5,347
Accrued expenses
37,222
24,514
20,446
2022 usd financing warrants
113,017
49,471
40,905
Total current liabilities
157,204
81,112
66,698
Credit facility, long-term
36,467
40,773
40,579
Other non-current liabilities
549
559
496
Total liabilities
194,220
122,444
107,773
Additional paid-in capital
1,737,018
937,795
913,914
Accumulated other comprehensive income
417
824
1,085
Accumulated deficit
-818,756
-659,770
-582,672
Total shareholders' equity
918,679
278,849
332,327
Total liabilities and shareholders' equity
1,112,899
401,293
440,100
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
DFTX Balance Sheet Sankey Diagram
Sankey diagram visualizing DFTX balance sheet for the period
Cash and cash
equivalents
$655,267K
Short-term investments
$428,612K
Prepaid and other
current assets
$8,222K
Total current assets
$1,092,101K
Goodwill
$19,918K
Other non-current
assets
$880K
Total assets
$1,112,899K
Total liabilities and
shareholders' equity
$1,112,899K
Total shareholders'
equity
$918,679K
Total liabilities
$194,220K
Accumulated deficit
-$818,756K
Additional paid-in capital
$1,737,018K
Total current
liabilities
$157,204K
Credit facility,
long-term
$36,467K
Other non-current
liabilities
$549K
Accumulated other
comprehensive income
$417K
2022 usd financing
warrants
$113,017K
Accrued expenses
$37,222K
Accounts payable
$6,965K
Buy us a coffee
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)